Drug Pipeline

Natural Killer Cell Therapy Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT05588453
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of…		 Enrollment reduced: 30 -> 24 participants
2026-06-12 NCT05588453
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of…		 date change Primary completion pushed: 2026-04-15 -> 2027-04-15
2026-06-12 NCT05588453
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of…		 date change Completion pushed: 2026-04-15 -> 2027-04-15
Active Studies by Phase
Phase 1/2
1
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05588453 Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of… Clinical Stage IV Cutaneous Melanoma AJCC v8 Recruiting
Phase 1
NCT04848064 Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or… Recurrent Adult T-Cell Leukemia/Lymphoma Recruiting
Early Phase 1
NCT07144384 Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and… Skin Basal Cell Carcinoma Recruiting
Sponsors Running Natural Killer Cell Therapy Trials
John Reneau (1) Kari Kendra (1) Kirsten Johnson (1)
Disease Areas
Leukemia (1) Non-Hodgkin Lymphoma (1) Melanoma (1)
Get alerts when Natural Killer Cell Therapy trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free